Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03687892 · ClinicalTrials.gov registry record · NA
Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT03687892: Clinical Trial NA study, sponsored by Stanford University.
NCT03687892 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03687892, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The investigators plan to use functional magnetic resonance imaging (fMRI) methods to assess brain changes following spaced theta burst stimulation (TBS), a new form of repetitive transcranial magnetic stimulation (rTMS), in 10 healthy participants. The investigators will measure the effects of both excitatory (intermittent, iTBS) and inhibitory (continuous, cTBS) TBS applied to the motor cortex, a system that when stimulated produces a readily observable behavioral response (e.g., movement of a given body regions). In addition to brain activity, we will assess the effects of TBS on motor responses and pain perception. The goal is to determine how brain activity and blood flow during tasks and at rest change following the applications of spaced cTBS and iTBS. Additionally, the aim is to determine the duration of the spaced TBS effects on brain activity and behavior. This study will provide an understanding of the functional brain and behavioral changes that occur following spaced TBS to the motor cortex and has implications for reducing the long treatment schedules associated with classical rTMS protocols.
Interventions
- DEVICE intermittent Theta Burst Stimulation
- DEVICE continuous Theta Burst Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2022-10-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03687892
The ClinicalTrials.gov registry entry for NCT03687892 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which intermittent Theta Burst Stimulation is the first listed.
NCT03687892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03687892 about?
NCT03687892 is a clinical study titled "Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation". The investigators plan to use functional magnetic resonance imaging (fMRI) methods to assess brain changes following spaced theta burst stimulation (TBS), a new form of repetitive transcranial magnetic stimulation (rTMS), in 10 healthy participants. The investigators will measure the effects of both...
What is the current status of trial NCT03687892?
This trial is currently terminated. It is a NA study. The enrollment target is 37 participants. The study started on 2019-04-01. Estimated completion is 2022-10-22.
What interventions are being tested in trial NCT03687892?
The interventions under investigation include: intermittent Theta Burst Stimulation (DEVICE), continuous Theta Burst Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03687892?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.